Provided by Tiger Trade Technology Pte. Ltd.

Molecular Partners AG

4.59
-0.1049-2.24%
Post-market: 4.590.00000.00%16:10 EDT
Volume:2.72K
Turnover:12.42K
Market Cap:171.48M
PE:-2.20
High:4.72
Open:4.68
Low:4.39
Close:4.69
52wk High:5.36
52wk Low:3.36
Shares:37.40M
Float Shares:14.89M
Volume Ratio:0.29
T/O Rate:0.02%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.0808
EPS(LYR):-2.0808
ROE:-55.55%
ROA:-26.59%
PB:1.68
PE(LYR):-2.20

Loading ...

Analysts Offer Insights on Healthcare Companies: ProKidney (PROK), Molecular Partners (MOLN) and Bristol-Myers Squibb (BMY)

TIPRANKS
·
Mar 19

Molecular Partners Presents New Preclinical Data Highlighting Radio-DARPins’ Amenability to Multiple Isotopes

GlobeNewswire
·
Mar 19

Molecular Partners to Hold Three Poster Presentations at AACR 2026

GlobeNewswire
·
Mar 18

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:54 PM

Reuters
·
Mar 17

Molecular Partners (MOLN) Gets a Buy from Clear Street

TIPRANKS
·
Mar 13

Molecular Partners Reports Highlights and Financial Results for Full Year 2025

GlobeNewswire
·
Mar 13

Molecular Partners AG expected to post a loss of 29 rappen a share - Earnings Preview

Reuters
·
Mar 10

Molecular Partners Announces Participation in March Investor Conferences and Upcoming 2025 Financial Results

GlobeNewswire
·
Feb 26

Molecular Partners Signs Development Agreement with Eckert & Ziegler for Targeted Alpha Radiotherapeutics

GlobeNewswire
·
Feb 26

Analysts Offer Insights on Healthcare Companies: Molecular Partners (MOLN) and SI-Bone (SIBN)

TIPRANKS
·
Feb 03

Molecular Partners Announces Presentation of First Imaging and Dosimetry Data of DLL3-Targeting Radiotherapy MP0712 in Patients at TWC 2026

GlobeNewswire
·
Feb 02

HC Wainwright Initiates Molecular Partners AG at Buy

MT Newswires Live
·
Jan 27

Molecular Partners Ag : H.c. Wainwright Initiates Coverage With Buy Rating; Target Price $13

THOMSON REUTERS
·
Jan 27

Molecular Partners initiated with a Buy at H.C. Wainwright

TIPRANKS
·
Jan 27

Molecular Partners (MOLN) Gets a Buy from LifeSci Capital

TIPRANKS
·
Jan 20

Molecular Partners provided update on latest progress, 2026 milestones

TIPRANKS
·
Jan 12

Molecular Partners Highlights Clinical Development Progress and Anticipated Milestones at 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire
·
Jan 12

Press Release: Molecular Partners Forms Scientific Advisory Board to Accelerate Development of Targeted Radiotherapeutics

Dow Jones
·
Dec 11, 2025

Molecular Partners Presents Updated Data from Ongoing Phase 1/2a Trial of MP0533 in AML at ASH Annual Meeting

GlobeNewswire
·
Dec 07, 2025

Molecular Partners presents new MP0712 data

TIPRANKS
·
Nov 12, 2025